Genmab A/S Stock

Genmab A/S ROIC

The Return on Invested Capital (ROIC) of Genmab A/S (GMAB.CO) as of Jul 28, 2026 is 8.54 %. In the previous year, Return on Invested Capital (ROIC) was 21.72 % — a change of -60.67% (lower).

ROIC

8.54 %

YoY

-60.67%

Last updated:

Return on Invested Capital (ROIC) of Genmab A/S is 2026 8.54 % . Return on Invested Capital (ROIC) of Genmab A/S was 2025 21.72 % . It decreases by -60.67% lower compared to the previous year.
Access this data via the Eulerpool API

Genmab A/S Stock analysis

What does Genmab A/S do? Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genmab A/S stock

Return on Invested Capital (ROIC) of Genmab A/S is 8.54 % in 2026.

Access this data via the Eulerpool API

Profitability — Genmab A/S

All Key Metrics — Genmab A/S